Form 8-K  (3/10/03)  (N0421113.DOC;1)



SECURITIES AND EXCHANGE COMMISSION


Washington, D.C.  20549



FORM 8-K



CURRENT REPORT



Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934




Date of Report (Date of earliest event reported):  April 14, 2003




METROPOLITAN HEALTH NETWORKS, INC.

(Exact name of registrant as specified in its charter)




_________Florida__________

______333-5884-A______

_____65-0635748_____

(State or other jurisdiction

(Commission File

(IRS Employer

or incorporation)

Number)

Identification No.)



250 Australian Avenue South, Suite 400, West Palm Beach, Florida 33401

(Address of principal executive offices, including zip code)



Registrant's telephone number, including area code       (561) 805-8500



ITEM 7.  FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS.


The Company's consolidated financial statements and related notes have been corrected to reflect restatements to 2001 and 2000 medical costs for certain capitation payments (expenses) that were made directly by the HMO to doctors under its management but were excluded from medical costs during those years in error.  The effect on the balance sheet at December 31, 2001, is to decrease accounts receivable and stockholder’s equity by approximately $1,983,000.  The effect on 2000 income before taxes and net income amounts previously reported is to decrease income before taxes and net income by approximately $605,000.  The effect on 2000 earnings per share is to decrease basic and diluted earnings per share by $0.03, and $0.03 respectively.  The effect on 2001 income before taxes and net income amounts previously reported is to decrease those amounts by approximately $1,378,000.  The effect on 2001 basic earnings per share and diluted earnings per share is to decrease those amounts by $0.06.


The errors were the result of missing data on certain HMO reports, and were made by an outside HMO accounting expert hired by Company on a regular basis for the single purpose of gathering, processing and summarizing HMO data for use by the Company in preparing financial statements.  The consultant’s summary schedules form the basis for recordation of certain medical revenues and expenses by the Company.  


Since the expansion of its PSN operations in 2000, management has relied on the outside consultant to analyze its HMO revenues, expenses and accounts receivable on a quarterly and annual basis, based on reports he receives from the HMO.  During 2002, management, while continuing to utilize his services, began placing less reliance on the consultant, instead further developing certain internal procedures to analyze HMO results.



 

Q2 2000

Q3 2000

Q4 2000

Q1 2001

Q2 2001

Q3 2001

Q4 2001

Q1 2002

Q2 2002

          

Medical costs, as reported

 26,944,578

   24,629,578

 29,626,818

   25,589,600

   25,795,961

   27,252,555

    34,283,191

    29,099,903

    34,109,555

Effect of restatement

      111,026

        145,715

      348,677

        346,436

        342,576

        347,132

         341,851

         347,715

    (2,331,128)

Medical costs, restated

 27,055,604

   24,775,411

 29,975,495

   25,936,036

   26,138,537

   27,599,687

    34,625,042

    29,447,618

    31,778,427

          
          

Income before discontinued operations, as reported

      350,482

     4,141,145

      377,824

     1,325,721

     1,993,073

     1,434,352

    (3,121,344)

         841,381

    (4,395,430)

Effect of restatement

   (111,026)

     (145,715)

   (348,677)

     (346,436)

     (342,576)

     (347,132)

       (341,851)

       (347,715)

      2,331,128

Income before discontinued operations, restated

      239,456

     3,995,430

        29,147

        979,285

     1,650,497

     1,087,220

    (3,463,195)

         493,666

    (2,064,302)

          
          

Income before income taxes, as reported

      350,482

     4,141,145

      283,113

     1,190,732

     1,829,943

     1,390,512

    (3,338,606)

         799,578

    (4,422,696)

Effect of restatement

   (111,026)

     (145,715)

   (348,677)

     (346,436)

     (342,576)

     (347,132)

       (341,851)

       (347,715)

      2,331,128

Income before income taxes, restated

      239,456

     3,995,430

     (65,564)

        844,296

     1,487,367

     1,043,380

    (3,680,457)

         451,863

    (2,091,568)

          
          

Net income, as reported

      350,482

     4,141,145

      283,113

     1,190,732

     1,829,943

     1,326,685

    (3,338,606)

         799,578

    (4,422,696)

Effect of restatement

   (111,026)

     (145,715)

   (348,677)

     (346,436)

     (342,576)

     (347,132)

       (341,851)

       (347,715)

      2,331,128

Net income, restated

      239,456

     3,995,430

     (65,564)

        844,296

     1,487,367

        979,553

    (3,680,457)

         451,863

    (2,091,568)

          
          

Earnings per share, basic, as reported

            0.02

              0.23

            0.01

              0.05

              0.07

              0.05

             (0.12)

               0.03

             (0.15)

Effect of restatement

         (0.01)

           (0.01)

         (0.01)

           (0.01)

           (0.01)

           (0.01)

             (0.01)

             (0.01)

               0.08

Earnings per share, basic, restated

            0.01

              0.22

                  -

              0.04

              0.06

              0.04

             (0.13)

               0.02

             (0.07)

          
          

Earnings per share, diluted, as reported

            0.01

              0.20

            0.01

            0.05

              0.06

              0.04

             (0.12)

               0.03

             (0.15)

Effect of restatement

                  -

           (0.01)

         (0.01)

           (0.02)

           (0.01)

           (0.01)

             (0.01)

             (0.02)

               0.08

Earnings per share, diluted, restated

            0.01

              0.19

                  -

            0.03

              0.05

              0.03

             (0.13)

               0.01

             (0.07)




 

As of

6/30/00

As of

9/30/00

As of

12/31/00

As of

3/31/01

As of

6/30/01

As of

9/30/01

As of

12/31/01

As of

3/31/02

         

Accounts receivable, as reported

    4,992,418

     6,960,693

    7,170,480

     9,001,239

   10,507,168

   13,382,946

     13,362,782

     16,709,790

Effect of restatement

    (111,026)

     (256,741)

     (605,418)

     (951,854)

  (1,294,430)

  (1,641,562)

    (1,983,413)

    (2,331,128)

Accounts receivable, restated

    4,881,392

     6,703,952

    6,565,062

     8,049,385

     9,212,738

   11,741,384

     11,379,369

     14,378,662

         

Retained earnings, as reported

(22,788,798)

(18,647,651)

(18,584,540)

(17,393,808)

(15,563,864)

(14,237,1790

  (17,575,786)

  (16,776,208)

Effect of restatement

     (111,026)

     (256,741)

     (605,418)

     (951,854)

  (1,294,430)

  (1,641,562)

    (1,983,413)

    (2,331,128)

Retained earnings, restated

(22,899,824)

(18,904,392)

(19,189,958)

(18,345,662)

(16,858,294)

(15,878,741)

  (19,559,199)

  (19,107,336)




SIGNATURE


Pursuant to the requirements of the Securities Exchange Act of 1934, Metropolitan Health Networks, Inc. has caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


METROPOLITAN HEALTH NETWORKS, INC.



 /s/  Michael M. Earley

Michael M. Earley

President & CEO



Dated:  April 16, 2003